Equities

SkinBioTherapeutics PLC

SBTX:LSE

SkinBioTherapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.15
  • Today's Change0.40 / 4.10%
  • Shares traded686.11k
  • 1 Year change-42.00%
  • Beta2.3127
Data delayed at least 20 minutes, as of May 17 2024 16:12 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at SkinBioTherapeutics PLC fell by 493.09k. Cash Flow from Financing totalled 2.32m or 1,754.75% of revenues. In addition the company used 2.65m for operations while cash used for investing totalled 165.28k.
Cash flow per share-0.0161
Price/Cash flow per share--
Book value per share0.0192
Tangible book value per share0.0152
More ▼

Balance sheet in GBPView more

SkinBioTherapeutics PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio6.57
Quick ratio6.48
Total debt/total equity0.0266
Total debt/total capital0.0259
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.